
Artist rendering of exterior of Western’s Bioconvergence Centre. (HOK/aTRR)
Changing how innovation happens
The Bioconvergence Centre will be located between the Schulich School of Medicine & Dentistry and the Faculty of Science, on the site currently occupied by the Molecular Biology Laboratory, Health Sciences Addition, Kresge and Natural Sciences Centre buildings. Construction is expected to start in 2027, with the building set to open in 2031. Upon completion, Western will join a handful of globally recognized institutes in the bioconvergence field – Harvard, MIT, Stanford and UC Berkeley. Western’s will be the first centre in Canada built specifically for bioconvergence. Its focus will be turning research into real-world patient care through biotherapeutics, precision medicine, medical devices and wearable devices, using tools and systems including data science and AI, molecular technologies and clinical trials. The building’s design – with interdisciplinarity embedded in its very structure, bringing researchers from diverse fields together to solve challenges – was created to drive creative answers and advancements to critical health questions. The centre’s model will help remove barriers standing in the way of innovative ideas. “Canadians are facing increasingly complex challenges, including higher rates of cancer, neurodegenerative disease and chronic illness, compounded by an aging population. At the same time, scientific breakthroughs are accelerating,” said Florentine Strzelczyk, Western’s provost and vice-president (academic). “The problem is not a lack of talent, but the gap between discoveries and reaching the market and patients. Western’s Bioconvergence Centre is designed to close that gap.”
Artist rendering of interior of Western’s Bioconvergence Centre. (HOK/aTRR)












